Photoirritation and Photoallergic Potential of a New Nicotine Patch

NCT00966901 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Nicotine Patch
DRUG: Placebo Patch
DRUG: No Patch Control
RADIATION: UVA and UVB irradiation

Sponsor

McNeil AB